In vitro activity of OPT-80 against Clostridium difficile
- PMID: 15155234
- PMCID: PMC415632
- DOI: 10.1128/AAC.48.6.2280-2282.2004
In vitro activity of OPT-80 against Clostridium difficile
Abstract
Clostridium difficile remains the major cause of nosocomial diarrhea. Reports on impaired susceptibility of C. difficile to metronidazole and vancomycin and frequent relapses of patients after therapy necessitate the search for new substances. With this study, the activity of OPT-80, a new macrocycle, against 207 C. difficile strains and against other obligately anaerobic bacteria was tested. OPT-80 showed high in vitro activity against all C. difficile strains tested.
References
-
- Brazier, J. S., W. Fawley, J. Freeman, and M. H. Wilcox. 2001. Reduced susceptibility of Clostridium difficile to metronidazole. J. Antimicrob. Chemother. 48:741-742. - PubMed
-
- Deutsches Institut für Normung. 2000. Medizinische Mikrobiologie und Immunologie: Diagnostische Verfahren. Deutsches Institut für Normung, Berlin, Germany.
-
- Fekety, R., L. V. McFarland, C. M. Surawicz, R. N. Greenberg, G. W. Elmer, and M. E. Mulligan. 1997. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin. Infect. Dis. 24:324-333. - PubMed
-
- Jang, S. S., L. M. Hansen, J. E. Breher, D. A. Riley, K. D. Madigan, Y. J. Tang, J. Silva, Jr., and D. C. Hirsh. 1997. Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains. Clin. Infect. Dis. 25:S266-S267. - PubMed
-
- Kyne, L., M. B. Hamel, R. Polavaram, and C. P. Kelly. 2002. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin. Infect. Dis. 34:346-353. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
